Osaic Holdings’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
Osaic Holdings's LUCD Position: Q1 2026 in Review
Osaic Holdings increased its Lucid Diagnostics (LUCD) stake by 31% in Q1 2026, buying an estimated $6.82K and bringing the position to 22,770 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5690.
Osaic Holdings first reported a position in LUCD in Q2 2022 and has held it in 16 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- Osaic Holdings held 22,770 shares of Lucid Diagnostics worth $26.2K as of Q1 2026.
- Osaic Holdings bought 5,360 Lucid Diagnostics shares in Q1 2026, an estimated $6.82K.
- Lucid Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5690 holding.
- Osaic Holdings first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 16 quarters since.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.